OB/GYN Clinical Alert – August 1, 2009
August 1, 2009
View Issues
-
Obesity and Oral Contraceptive Efficacy
A large prospective randomized trial (n = 2812 women) was retrospectively analyzed to look at contraceptive efficacy and weight/BMI. -
The Raloxifene RUTH Trial Subgroup Analysis
The raloxifene use for the heart (RUTH) trial was an international randomized, placebo-controlled trial that enrolled 10,101 postmenopausal women in two groups, one at high risk for coronary heart disease, and one with established coronary heart disease. -
Use of Magnesium Sulfate as a Neuroprotector
June seems to have been magnesium sulfate month in both the Obstetrics & Gynecology and American Journal of Obstetrics & Gynecology journals. -
Emergence of True "Individualized" Therapy: The PARP Inhibitors
Preclinical data recently demonstrated the extreme sensitivity of BRCA-deficient cells to inhibition of the single-strand repair enzyme poly(ADP-ribose) polymerase (PARP). -
Special Feature: A Warm Thank You
About 30 years ago (so long ago that I can't remember the exact year), I began to edit a monthly newsletter devoted to reproductive medicine. -
Pharmacology Watch: Meta-analysis Compares Antihypertensive Classes
In this issue: Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions. -
Clinical Briefs in Primary Care supplement